Patents by Inventor Dewayne Townsend

Dewayne Townsend has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8580245
    Abstract: The present invention relates to compositions and methods for treating and preventing heart disease. In particular, the present invention provides compositions comprising poloxamers (e.g., poloxamer 188-P188) and methods of using the same for treating and preventing heart disease (e.g., in subjects with muscular dystrophy) and for treating cells and tissue damage caused by ischemia and cell death (e.g., for treating dystrophin-deficient cells (e.g., myocytes)).
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: November 12, 2013
    Assignee: The Regents of the University of Michigan
    Inventors: Joseph M. Metzger, Dewayne Townsend, Soichiro Yasuda, Daniel E. Michele
  • Publication number: 20110044935
    Abstract: The present invention relates to compositions and methods for treating and preventing heart disease. In particular, the present invention provides compositions comprising poloxamers (e.g., poloxamer 188-P188) and methods of using the same for treating and preventing heart disease (e.g., in subjects with muscular dystrophy) and for treating cells and tissue damage caused by ischemia and cell death (e.g., for treating dystrophin-deficient cells (e.g., myocytes)).
    Type: Application
    Filed: October 29, 2010
    Publication date: February 24, 2011
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Joseph M. Metzger, Dewayne Townsend, Soichiro Yasuda, Daniel E. Michele
  • Patent number: 7846426
    Abstract: The present invention relates to compositions and methods for treating and preventing heart disease. In particular, the present invention provides compositions comprising poloxamers (e.g., poloxamer 188—P188) and methods of using the same for treating and preventing heart disease (e.g., in subjects with muscular dystrophy) and for treating cells and tissue damage caused by ischemia and cell death (e.g., for treating dystrophin-deficient cells (e.g., myocytes)).
    Type: Grant
    Filed: February 27, 2006
    Date of Patent: December 7, 2010
    Assignee: The Regents of the University of Michigan
    Inventors: Joseph M. Metzger, Dewayne Townsend, Soichiro Yasuda, Daniel E. Michele
  • Publication number: 20080260681
    Abstract: The present invention relates to compositions and methods for treating and preventing heart disease. In particular, the present invention provides compositions comprising poloxamers (e.g., poloxamer 188-P1 88) and methods of using the same for treating and preventing heart disease (e.g., in subjects with muscular dystrophy) and for treating cells and tissue damage caused by ischemia and cell death (e.g., for treating dystrophin-deficient cells (e.g., myocytes)).
    Type: Application
    Filed: February 27, 2006
    Publication date: October 23, 2008
    Inventors: Joseph M. Metzger, Dewayne Townsend, Soichiro Yasuda, Daniel E. Michele